Lifestyle and clinical factors associated with elevated C-reactive protein among newly diagnosed Type 2 diabetes mellitus patients: a cross-sectional study from the nationwide DD2 cohort

Table 2 Regression analysis of biomarkers and the association with CRP levels in 1037 patients with newly diagnosed Type 2 DM patients

	B-coeff Crude (95%CI)	Stand. Beta Crude (95%CI)	B-coeff Model 1^a(95%CI)	Stand. Beta Model 1^a(95%CI)	B-coeff Model 2^b(95%CI)	Stand. Beta Model 2^b(95%CI)	B-coeff. Model 3^c(95%CI)	Stand. Beta Model 3^c(95%CI)
ALAT^d	0.025	0.06	0.024	0.05	-0.003	-0.009	-0.01	-0.03
ALAT^d	(-0.003,0.05)	(-0.0006,0.12)	(-0.002,0.05)	(-0.005,0.11)	(-0.03,0.02)	(-0.07,0.05)	(-0.05, 0.04)	(-0.13,0.07)
Amylase^d	-0.019	-0.04	-0.013	-0.03	-0.001	-0.002	0.03	0.06
Amylase^d	(-0.048,0.01)	(-0.01,-0.06)	(-0.04,0.017)	(-0.09,0.04)	(-0.33, 0.03)	(-0.07,0.06)	(-0.01, 0.08)	(-0.04,0.17)
C-peptide^d	0.12	0.29	0.12	0.29	0.05	0.0004	0.02	0.07
C-peptide^d	(0.09-0.14)	(0.23,0.35)	(0.098,0.14)	(0.23-0.35)	(0.03,0.07)	(-0.05,0.05)	(-0.01, 0.06)	(-0.02,0.16)
Fasting blood glucose^d	0.03	0.19	0.03	0.2	0.03	0.15	0.03	0.14
Fasting blood glucose^d	(0.02,0.04)	(0.13,0.24)	(0.02,0.04)	(0.11,0.23)	(0.015-0.04)	(0.08,0.21)	(0.006, 0.04)	(0.03,0.25)

^aAdjusted for age and gender.
^bAdjusted for age, gender, central obesity.
^cAdjusted for age, gender central obesity, all biomarkers (except when stratified by given variable).
^dAll biomarkers (including CRP) are log transformed.

ISSN: 1472-6823